Cargando…
Circulating alarin concentrations are high in patients with type 2 diabetes and increased by glucagon-like peptide-1 receptor agonist treatment: An Consort-compliant study
CONTEXT: Alarin has been reported to be relative to food intake and an increase in body weight. However, to date, no report has demonstrated the relationship between circulating alarin and diabetes in humans. OBJECTIVE: The objective of this study is to gain insight into the possible role of alarin...
Autores principales: | Hu, Wenjing, Fan, Xiaoyun, Zhou, Baoyong, Li, Ling, Tian, Bo, Fang, Xia, Xu, Xiaohui, Liu, Hua, Yang, Gangyi, Liu, Yongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6641675/ https://www.ncbi.nlm.nih.gov/pubmed/31305464 http://dx.doi.org/10.1097/MD.0000000000016428 |
Ejemplares similares
-
Thermoregulatory effect of alarin, a new member of the galanin peptide family
por: Mikó, Alexandra, et al.
Publicado: (2014) -
Distribution of Alarin Immunoreactivity in the Mouse Brain
por: Eberhard, Nicole, et al.
Publicado: (2011) -
Circulating Levels of CILP2 Are Elevated in Coronary Heart Disease and Associated with Atherosclerosis
por: Hu, Wenjing, et al.
Publicado: (2020) -
Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
por: Lee, Seungah, et al.
Publicado: (2017) -
Synthesis and biological evaluation of glucagon-like peptide-1 receptor agonists
por: Zhang, Yu-Juan, et al.
Publicado: (2013)